Pharmaceutical

A rational design approach to RNA-targeting to target large-scale screening

At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.

Oct 4, 2024 - 04:00
A rational design approach to RNA-targeting to target large-scale screening
At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.
Read the original article

Tags:

Previous Article

FDA authorizes the first novel schizophrenia therapy in decades

Next Article

Resolution scores $83m to develop macrophage cell therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Valneva pushes FDA approval date for chikungunya vaccine

Valneva pushes FDA approval date for chikungunya vaccine

Aug 14, 2023

Johnson & Johnson antiviral pill for dengue shows early efficacy

Johnson & Johnson antiviral pill for dengue shows early...

Oct 24, 2023

STAT+: Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit

STAT+: Pharmalittle: Novo halts Ozempic kidney failure ...

Oct 12, 2023